$23.37
-0.21-0.89%
At close: -
$23.37
0.000.00%
After Hours: Mar 14, 4:00 PM EDT
Comments
Loading...
NewAmsterdam Pharma Co Earnings Estimates, EPS & Revenue | NASDAQ:NAMS | Benzinga
NewAmsterdam Pharma Co reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 26
EPS
$-0.510
Quarterly Revenue
$8.63M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$45.56M
Analyze the earnings history of NewAmsterdam Pharma Co using advanced sorting and filters.
Data brought to you by Benzinga APIs
NewAmsterdam Pharma Co (NAMS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
NewAmsterdam Pharma Co (NAMS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is NewAmsterdam Pharma Co (NASDAQ:NAMS) reporting earnings?
NewAmsterdam Pharma Co (NAMS) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for NewAmsterdam Pharma Co (NASDAQ:NAMS)?
The Actual EPS was $-0.51, which missed the estimate of $0.00.
What were NewAmsterdam Pharma Co’s (NASDAQ:NAMS) revenues?
The Actual Revenue was $8.6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.